RSV vaccines in older adults
RSV vaccination for adults aged 60 and older.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 7, 10, 22, 16, 19.
New guidelines and consensus this year
- [Vaccination of Older Adults in Portugal: Recommendations from the Geriatrics Study Group of the Portuguese Society of Internal Medicine]Acta Med Port2026 Mar 2
- Expert Consensus Statement on the Disease Burden and Vaccination for Respiratory Syncytial Virus Infection in AdultsTuberc Respir Dis (Seoul)2026 Jan
- Updated Swedish guidelines for the management and treatment of RSV infectionInfect Dis (Lond)2026 Jan
- Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal MedicinePulmonology2025 Dec 31
All papers from the last 12 months
284 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- RSV vaccine uptake among Medicare Advantage enrollees: August 2023 to December 2024Hum Vaccin Immunother2026 DecPMID 42872881
- Clinical and economic impact of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccination in older adults: a cost-effectiveness analysis for ChileExpert Rev Vaccines2026 DecPMID 42728842
- Priority setting for older adult vaccines in Indonesia: a multi-criteria decision analysis using SMART vaccinesExpert Rev Vaccines2026 DecPMID 42635066
- Consensus based expert recommendations for management and prevention of RSV infections in older adults in emerging market countries: results from an expert panel structured surveyExpert Rev Vaccines2026 DecPMID 42596759
- Advancing human metapneumovirus vaccine development through fusion protein stabilizationVirology2026 DecPMID 42566836Review
- Respiratory syncytial virus disease burden in adults aged ≥50 years old: A retrospective national surveillance database analysis in Mexico (2015-2023)Hum Vaccin Immunother2026 DecPMID 42525970
- Adult respiratory syncytial virus infection and community-acquired pneumonia: pathogenesis, diagnostic challenges and the clinical implicationsExpert Rev Vaccines2026 DecPMID 42498978Review
- Quantifying the societal benefits of adult immunization against respiratory diseases in France: a benefit cost analysisExpert Rev Vaccines2026 DecPMID 42484014
- Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysisExpert Rev Vaccines2026 DecPMID 42384548
- From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virusExpert Rev Vaccines2026 DecPMID 42257651Review
More infectious diseases trends
All specialties →Long-acting HIV prevention
Lenacapavir and cabotegravir injections for HIV pre-exposure prophylaxis.
Candida auris
A multidrug-resistant fungus spreading in healthcare settings.
Metagenomic sequencing diagnostics
Metagenomic next-generation sequencing to identify pathogens.
New antibiotics for resistant Gram-negatives
Cefiderocol, sulbactam-durlobactam and other new agents.
Shorter regimens for tuberculosis
Bedaquiline, pretomanid and other shorter TB regimens.
Key point: For adolescents aged 14 years and above and adults with MDR/RR-TB, 6-month BPaLM is recommended over 9-month or longer regimens.
H5N1 avian influenza
H5N1 bird flu in animals and humans.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
("respiratory syncytial virus"[tiab] OR RSV[tiab]) AND vaccin*[tiab] AND ("older adults"[tiab] OR elderly[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.